IUPAC/Chemical Name
2H-1,3-Oxazine-2,4(3H)-dione, 5-beta-D-ribofuranosyl-
InChi Key
REFHNSOTFKKRAI-GBNDHIKLSA-N
InChi Code
InChI=1S/C9H11NO7/c11-1-4-5(12)6(13)7(17-4)3-2-16-9(15)10-8(3)14/h2,4-7,11-13H,1H2,(H,10,14,15)/t4-,5-,6-,7+/m1/s1
SMILES Code
O=C(N1)OC=C([C@H]2[C@@H]([C@@H]([C@@H](CO)O2)O)O)C1=O
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
245.19
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Isono K, Suhadolnik RJ. Biosynthesis of the C-nucleoside, minimycin: asymmetric incorporation of glutamate and acetate into the oxazine ring. J Antibiot (Tokyo). 1977 Mar;30(3):272-3. PubMed PMID: 863787.
2: Kusakabe Y, Nagatsu J, Shibuya M, Kawaguchi O, Hirose C. Minimycin, a new antibiotic. J Antibiot (Tokyo). 1972 Jan;25(1):44-7. PubMed PMID: 5010645.
3: Isono K, Uzawa J. 13C-NMR evidence for the biosynthetic incorporation of acetate into minimycin and compounds related to Krebs cycle. FEBS Lett. 1977 Aug 1;80(1):53-6. PubMed PMID: 891969.
4: Isono K, Suhadolnik RJ. The biosynthesis of the nucleoside antibiotics: minimycin formation by Streptomyces hygroscopicus. Ann N Y Acad Sci. 1975 Aug 8;255:390-401. PubMed PMID: 1059367.
5: Sasaki K, Kusakabe Y, Esumi S. The structure of minimycin, a novel carbon-linked nucleoside antibiotic related to -pseudouridine. J Antibiot (Tokyo). 1972 Mar;25(3):151-4. PubMed PMID: 5034811.
6: De Bernardo S, Weigele M. Synthesis of oxazinomycin (minimycin). J Org Chem. 1977 Jan 7;42(1):109-12. PubMed PMID: 830847.
7: Walker MG, Blum R, Fagan LM. Minimycin: a miniature rule-based system. MD Comput. 1985 Jul-Aug;2(4):21-7, 46. PubMed PMID: 3916115.
8: Tymiak AA, Culver CA, Goodman JF, Seiner VS, Sykes RB. Oxazinomycin produced by a Pseudomonas species. J Antibiot (Tokyo). 1984 Apr;37(4):416-8. PubMed PMID: 6725147.
9: Buchanan JG. The C-nucleoside antibiotics. Fortschr Chem Org Naturst. 1983;44:243-99. Review. PubMed PMID: 6360831.
10: Kitani S, Kinoshita H, Nihira T, Yamada Y. In vitro analysis of the butyrolactone autoregulator receptor protein (FarA) of Streptomyces lavendulae FRI-5 reveals that FarA acts as a DNA-binding transcriptional regulator that controls its own synthesis. J Bacteriol. 1999 Aug;181(16):5081-4. PubMed PMID: 10438782; PubMed Central PMCID: PMC93999.
11: Srivastava PC, Robins RK. Synthesis and biological activity of certain derivatives of oxazinomycin and related oxadiazole nucleosides. J Med Chem. 1981 Oct;24(10):1172-7. PubMed PMID: 6276541.
12: Viti C, Pace A, Giovannetti L. Characterization of Cr(VI)-resistant bacteria isolated from chromium-contaminated soil by tannery activity. Curr Microbiol. 2003 Jan;46(1):1-5. PubMed PMID: 12432455.
13: Ruengjitchatchawalya M, Nihira T, Yamada Y. Purification and characterization of the IM-2-binding protein from Streptomyces sp. strain FRI-5. J Bacteriol. 1995 Feb;177(3):551-7. PubMed PMID: 7836286; PubMed Central PMCID: PMC176627.
